Kour & Kour - Xarelto. The right anitode, how we armed Bayer introduce the novel oral anticoagulant

Xarelto. The right anitode, how we armed Bayer introduce the novel oral anticoagulant

WHAT WAS THE CHALLENGE.

Xarelto is indicated to reduce risk of blood clots with proven protection. Bayer wanted to innovatively position the novel prescription and application amongst leading HCPs.

WHAT WE HAVE DONE.

- Event concept, design development and implementation

- Interactive presentation

- Event communication strategy and development

- Direct-to-doctor communication

- Invitation cards and collateral